AbbVie Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 74.9% | 12.6% | 7.9% |
| FY2022 | 68.6% | 14.7% | 8.5% |
| FY2023 | 46.9% | 7.0% | 3.6% |
| FY2024 | 128.7% | 6.1% | 3.2% |
| FY2025 | -129.2% | 6.9% | 3.2% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 74.9% | 12.6% | 7.9% |
| FY2022 | 68.6% | 14.7% | 8.5% |
| FY2023 | 46.9% | 7.0% | 3.6% |
| FY2024 | 128.7% | 6.1% | 3.2% |
| FY2025 | -129.2% | 6.9% | 3.2% |